These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2404226)

  • 41. Safety and efficacy of posaconazole in the long-term treatment of azole-refractory oropharyngeal and esophageal candidiasis in patients with HIV infection.
    Vazquez JA; Skiest DJ; Tissot-Dupont H; Lennox JL; Boparai N; Isaacs R
    HIV Clin Trials; 2007; 8(2):86-97. PubMed ID: 17507324
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The usage of micomax in the treatment of oral leptotrichiosis and candidosis].
    Tsarev VN; Dmitrieva LA
    Stomatologiia (Mosk); 2003; 82(3):63-4. PubMed ID: 12841147
    [No Abstract]   [Full Text] [Related]  

  • 43. [Successful treatment of oro-pharyngo-oesophageal Candida albicans infection after renal transplantation (author's transl)].
    Zazgornik J; Kaiser R; Kopsa H; Schmidt P; Pötzi ; Hruby K
    Mykosen; 1978 Feb; 21(2):33-8. PubMed ID: 345119
    [No Abstract]   [Full Text] [Related]  

  • 44. [Drug therapy of mycoses in otorhinolaryngology].
    Constantinescu F; Midan F
    Otorinolaringologie; 1972; 17(3):211-6. PubMed ID: 5030472
    [No Abstract]   [Full Text] [Related]  

  • 45. Diagnosis and management of oral candidiasis.
    Giannini PJ; Shetty KV
    Otolaryngol Clin North Am; 2011 Feb; 44(1):231-40, vii. PubMed ID: 21093632
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fungal infections of the oral mucosa.
    Krishnan PA
    Indian J Dent Res; 2012; 23(5):650-9. PubMed ID: 23422613
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Topical steroid and antifungal agent in the treatment of oral lichen planus: report of 2 cases].
    Luangjarmekorn L; Jainkittivong A
    J Dent Assoc Thai; 1986; 36(1):9-16. PubMed ID: 3465765
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment strategies for oropharyngeal candidiasis.
    Laudenbach JM; Epstein JB
    Expert Opin Pharmacother; 2009 Jun; 10(9):1413-21. PubMed ID: 19505211
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune defence mechanisms and immunoenhancement strategies in oropharyngeal candidiasis.
    Villar CC; Dongari-Bagtzoglou A
    Expert Rev Mol Med; 2008 Oct; 10():e29. PubMed ID: 18847522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
    Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
    Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmaceutical prescribing for children. Part 4. Antifungal and antiviral therapy.
    Martin MV
    Prim Dent Care; 2006 Apr; 13(2):59-61. PubMed ID: 16608598
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oropharyngeal candidiasis in patients with HIV: suggested guidelines for therapy.
    Powderly WG; Gallant JE; Ghannoum MA; Mayer KH; Navarro EE; Perfect JR
    AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1619-23. PubMed ID: 10606084
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Oral candidosis].
    Olsen I; Pedersen KN
    Nor Tannlaegeforen Tid; 1972 Jun; 82(6):317-24. PubMed ID: 4563281
    [No Abstract]   [Full Text] [Related]  

  • 55. Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats.
    Martinez A; Regadera J; Jimenez E; Santos I; Gargallo-Viola D
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1008-13. PubMed ID: 11257009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment for oropharyngeal candidiasis.
    Fasciana GS
    J Am Dent Assoc; 1984 Mar; 108(3):300, 302. PubMed ID: 6585401
    [No Abstract]   [Full Text] [Related]  

  • 57. Oral candidiasis: pathogenesis, clinical presentation, diagnosis and treatment strategies.
    Lalla RV; Patton LL; Dongari-Bagtzoglou A
    J Calif Dent Assoc; 2013 Apr; 41(4):263-8. PubMed ID: 23705242
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Progressive resistance to fluconazole in a patient with HIV infection and recurrent oropharyngeal candidiasis].
    Corzo Delgado JE; Lozano de León F; Aretio Najarro R; Martín Mazuelos E
    Med Clin (Barc); 1994 Nov; 103(16):639. PubMed ID: 7996928
    [No Abstract]   [Full Text] [Related]  

  • 59. Candidosis of the oral cavity. Recognition and management.
    Hay KD
    Drugs; 1988 Nov; 36(5):633-42. PubMed ID: 3063501
    [No Abstract]   [Full Text] [Related]  

  • 60. Candida-Associated Cheilitis.
    Ohta K; Yoshimura H
    Am J Med Sci; 2020 Dec; 360(6):e17-e18. PubMed ID: 32684336
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.